NUTRA PHARMA CORP. Net Income (Loss) Available to Common Stockholders, Diluted
NUTRA PHARMA CORP. (NPHC) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$3.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-19
- NUTRA PHARMA CORP. net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was -$3.95M, a 947.38% decline year-over-year.
- NUTRA PHARMA CORP. net income (loss) available to common stockholders, diluted for the quarter ending 2025-06-30 was $466.00K.
- NUTRA PHARMA CORP. net income (loss) available to common stockholders, diluted for the quarter ending 2024-06-30 was -$367.14K.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month |
|---|---|
| 2026-06-30 | -$3.95M 10-Q · filed 2026-08-19 |
| 2025-06-30 | $466.00K 10-Q · filed 2026-08-19 |
| 2024-06-30 | -$367.14K 10-Q · filed 2026-03-25 |